Congratulations to Michael Haller on being elected Chairman of Type 1 Diabetes TrialNet! This appointment recognizes Dr. Haller’s leadership and longstanding commitment to advancing research for the prediction, prevention, and treatment of Type 1 Diabetes. As Chair of TrialNet, Dr. Haller will help guide one of the world’s leading collaborative research networks focused on preventing and ultimately curing Type 1 Diabetes. We are so proud to celebrate this well-deserved recognition and look forward to the continued impact of his leadership on the future of diabetes research and patient care.
Please join us in congratulating Dr. Haller on this remarkable achievement!